# Adhezion Biomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/adhezion-biomedical

- Industry: Medical Devices & Equipment
- Headquarters: Wyomissing, US
- Website: www.adhezion.com
- Total disclosed funding: $5.1M
- Latest round: Series A (Nov 6, 2008)
- Investors on record: 2

## About

Founded in 2001 and headquartered in Wyomissing, US, Adhezion Biomedical LLC specializes in developing medical adhesives for surgical and wound management applications, enhancing healthcare solutions across diverse medical environments.Adhezion Biomedical LLC focuses on the innovation of medical adhesives for surgical and wound care. Founded in 2001 in Wyomissing, US, the company has completed a total of 5 deals, with the most recent deal occurring on July 25, 2012. Their latest round of funding was a VENTURE DEBT round, raising USD 0.25 mn, contributing to a total amount raised of USD 2.50 mn. The CEO, Pete Molinaro, leads the company towards its ongoing mission.Adhezion Biomedical LLC specializes in proprietary cyanoacrylate-based medical adhesives, focusing on surgical and wound care applications. Their key products include SurgiSeal® Topical Skin Adhesive for wound closure, FloraSeal® Microbial Sealant to prevent bacterial migration during surgeries, and SecurePortIV®, an adhesive for catheter securement. Their clientele consists of hospitals, surgical centers, and medical manufacturers, providing solutions in both acute and non-acute care environments, with a market presence in the US and internationally.Adhezion Biomedical LLC generates revenue through direct business transactions, supplying medical adhesives to healthcare facilities. Their business model primarily involves direct sales to hospitals and surgical centers, where products like SurgiSeal® and FloraSeal® are utilized in surgical and wound management scenarios. This model ensures a consistent demand for their products, supported by relationships with healthcare providers. Specific pricing details are not disclosed.Looking ahead, Adhezion Biomedical LLC is focused on developing new medical adhesive products and expanding into new markets. The company plans to launch additional products designed for enhanced surgical applications by 2025. Recent VENTURE DEBT funding raised on July 25, 2012, will be utilized to support these initiatives, facilitating their entry into additional international markets and broaden their product offerings.

## Funding rounds

- Series A, Nov 6, 2008, $2.1M — Liberty Venture Partners
- Series A, Apr 23, 2008, $3M — Originate Ventures

## Investors

- Originate Ventures (https://capitalatlas.ai/funds/originate-ventures) — Series A
- Liberty Venture Partners (https://capitalatlas.ai/funds/liberty-venture-partners) — Series A